Login / Signup

Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.

André Luis Pereira de AlbuquerqueMarcos Naoyuki SamanoSilvia Vidal CamposMartina Rodrigues de OliveiraJosé Eduardo Afonso JuniorRafael Medeiros CarraroRicardo Henrique Oliveira Braga TeixeiraIsabela Pasqualini MinguiniRoni BurlinaEduardo Zinoni Silva PatoCarlos Roberto Ribeiro CarvalhoAndré Nathan Costa
Published in: Lung (2017)
This data reinforces the role of LT for LAM patients with end-stage disease. The use of sirolimus seems to be safe before LT and the occurrence of complications after LT, including those LAM-related, should be continuously monitored.
Keyphrases
  • risk assessment
  • electronic health record
  • extracorporeal membrane oxygenation
  • big data
  • machine learning
  • data analysis
  • drug induced